Technology

Eloxx Pharmaceuticals

$4.13
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-1.20%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ELOX and other stocks, options, and ETFs commission-free!

About ELOX

Eloxx Pharmaceuticals, Inc. engages in the development of novel ribonucleic acid modulating drug candidates. The firm focuses on the the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. It operates through the United States and Israel geographical segments. Its product includes ELX-02, a small molecule drug designed to restore production of full-length functional proteins which treats cystic fibrosis and cystinosis. The company was founded by Silvia Noiman on December 19, 2017 and is headquartered in Waltham, MA. The listed name for ELOX is Eloxx Pharmaceuticals, Inc. Common Stock.

CEO
Gregory C. Williams
Employees
29
Headquarters
Waltham, Massachusetts
Founded
2017
Market Cap
159.88M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
70.84K
High Today
$4.23
Low Today
$3.90
Open Price
$4.12
Volume
101.57K
52 Week High
$6.77
52 Week Low
$1.44

Collections

ELOX Earnings

-$0.40
-$0.27
-$0.13
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 4, After Hours

You May Also Like

RYAM
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure